Routine blood test may predict increased mortality risk in COVID-19 patients, study finds

Routine blood test may predict increased mortality risk in COVID-19 patients, study finds
TORONTO -- U.S. scientists say they have identified a routine blood test that could help predict which COVID-19 patients admitted to hospital face a higher risk of becoming critically ill and dying from the virus.

The standardized blood test, known as the red cell distribution width (RDW) test, is typically used to help diagnose medical conditions such as anemia, heart disease and diabetes.

Now, researchers at Massachusetts General Hospital in Boston have found that the RDW test can also be linked to COVID-19 death rates.

The findings were published Wednesday in the journal JAMA Network Open.

The study looked at 1,641 adults diagnosed with SARS-CoV-2, the virus that causes COVID-19, and admitted to one of four hospitals in the Boston area between March 4 and April 28. Before looking for complicated changes in circulating blood cells, the scientists first searched for patterns using currently available blood tests.

"We wanted to help find ways to identify high-risk COVID patients as early and as easily as possible -- who is likely to become severely ill and may benefit from aggressive interventions, and which hospitalized patients are likely to get worse most quickly," senior author Dr. John Higgins said in the release.

The study found that patients who had an RDW value above the normal range when they were admitted to the hospital had a 2.7-times higher risk of dying, with a mortality rate of 31 per cent compared to 11 per cent in patients with normal RDW values.

The study also found a subsequent increase in RDW values after admission was associated with an even higher risk of dying. Researchers say these findings suggest that the RDW could be tracked during hospitalization to help determine whether patients are responding to treatment or getting worse.

The study noted that early reports from China indicated that the body s inflammatory response to the novel coronavirus was "extremely intense" in some patients and very mild in others. Previous work done by the researchers also revealed that certain changes in the numbers and types of blood cells during inflammation are associated with poor health outcomes in patients with diseases including heart disease, cancer, and diabetes.

Researchers said they are now looking into the mechanisms that cause RDW increases in severe COVID-19 cases to better protect those most at risk.

"Such discoveries could point to new treatment strategies or identify better markers of disease severity," co-author Aaron Aguirre said in the release.
Read more on CTVnews
News Topics :
Acute ischemic strokes AIS associated with COVID 19 are more severe, lead to worse functional outcomes and are associated with higher mortality , according to new research published yesterday in Stroke,...
Southampton researchers have identified a blood profile that could help identify COVID 19 patients at greatest risk of deterioration and direct them towards trials of specific treatments that could modify their...
New research from Wuhan, China shows that, in patients with COVID 19 but without a previous diagnosis of diabetes, abnormally high blood sugar is associated with more than double the risk...
A team from Lawson Health Research Institute and Western University has made significant steps forward in understanding COVID 19 through two back to back studies published this week in Critical Care Explorations. In...
Patients hospitalized with COVID 19 who had a combination of high blood pressure, obesity and diabetes were over three times more likely to die from the disease, according to a new...